Circadian Clock Dysregulation and Prostate Cancer: A Molecular and Clinical Overview.

"The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."

"Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Bridget Fortin was supported by the T32 Interdisciplinary Cancer Research (IDCR) Training Program (grant no. T32CA009054). The authors wish to acknowledge the support of the Chao Family Comprehensive Cancer Center (CFCCC) at the University of California, Irvine, which is supported by the National Institutes of Health (NIH)/National Cancer Institute (NCI) (grant no. P30 CA062203). Financial support for the Masri laboratory is provided through the NIH/NCI (grant nos R01CA244519 and R01CA259370), the V Foundation for Cancer Research, Johnson and Johnson, and support from the Anti-Cancer Challenge through the CFCCC."